Allergan, Inc. (NYSE: AGN) has proposed to acquire Inamed Corporation (NASDAQ: IMDC) for a per share consideration of $84.00 in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE